FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109931581> ?p ?o ?g. }

• W2109931581 endingPage "504" @default.
• W2109931581 startingPage "499" @default.
• W2109931581 abstract "Late relapses (>2 years) after completion of chemotherapy are rare and often platinum-resistant. There are limited data concerning late relapses in chemotherapy-naïve patients with stage I germ cell tumors. This retrospective analysis was performed to compare the outcome between patients with stage I germ cell tumors, who had late (≥2 years) and early (≥3 months and <2 years) relapse after orchiectomy. We analyzed data of 1,069 chemotherapy-naïve patients with advanced germ cell tumors of testis treated in our department from 1986 to 2008. All patients had cisplatin- and etoposide-based chemotherapy. We identified 169 (15.8%) patients with prior stage I disease, who had not received adjuvant treatment: 140 and 29 patients had early and late relapse, respectively. Among patients with late relapse, pure seminoma was revealed in 14 patients, and nonseminoma in 15 patients. Median follow-up time for 169 patients was 35 (range, 2–218) months. Patients with late relapse were older, 35 years (23–57) and had more frequent pure seminoma in primary tumor, 14/29 (48.3%), than patients with early relapse, 30 years (16–63) (P = 0.0008) and 46/140 (32,8%, P = 0.08), respectively. At the time of disease progression, both groups were very similar according to well-known prognostic factors including IGCCCG classification. The only difference was larger size of retroperitoneal lymph nodes in late (9 cm) than in early relapse (4 cm, P < 0.0001). The outcome in patients with late relapse was significantly worse than in patients with early relapse: complete response rate after induction chemotherapy was 20.7% (6/29) vs. 42.1% (59/140) (P = 0.01), 3-year progression-free survival 66% vs. 84% (P = 0.02, HR = 2.4, 95% CI 1.2–8.8) and 3-year overall survival, 72% vs. 88% (P = 0.04, HR = 2.4, 95% CI 1.05–10.25), respectively. In patients with pure seminoma, this difference in overall survival was even more significant: 65% vs. 91% (P = 0.04, HR = 3.8, 95% CI 1.06–32.4). Late relapses following stage I germ cell tumors were associated with seminoma, older age, and worse outcome after induction chemotherapy." @default.
• W2109931581 created "2016-06-24" @default.
• W2109931581 creator A5003431977 @default.
• W2109931581 creator A5012700479 @default.
• W2109931581 creator A5023328871 @default.
• W2109931581 creator A5037865295 @default.
• W2109931581 creator A5044713725 @default.
• W2109931581 creator A5047909222 @default.
• W2109931581 creator A5052686564 @default.
• W2109931581 creator A5056439371 @default.
• W2109931581 creator A5080856237 @default.
• W2109931581 creator A5086601750 @default.
• W2109931581 creator A5087735810 @default.
• W2109931581 date "2013-05-01" @default.
• W2109931581 modified "2023-10-02" @default.
• W2109931581 title "Late relapses (>2 years) in patients with stage I testicular germ cell tumors: Predictive factors and survival" @default.
• W2109931581 cites W1504438247 @default.
• W2109931581 cites W1578544063 @default.
• W2109931581 cites W1978174896 @default.
• W2109931581 cites W2034290314 @default.
• W2109931581 cites W2042763713 @default.
• W2109931581 cites W2048893650 @default.
• W2109931581 cites W2051090934 @default.
• W2109931581 cites W2076379009 @default.
• W2109931581 cites W2083683974 @default.
• W2109931581 cites W2085153854 @default.
• W2109931581 cites W2091256735 @default.
• W2109931581 cites W2107074225 @default.
• W2109931581 cites W2123514718 @default.
• W2109931581 cites W2140462124 @default.
• W2109931581 cites W2146770164 @default.
• W2109931581 cites W2163826522 @default.
• W2109931581 cites W2169428224 @default.
• W2109931581 cites W2218229785 @default.
• W2109931581 cites W2259767564 @default.
• W2109931581 cites W4210282201 @default.
• W2109931581 cites W89751860 @default.
• W2109931581 doi "https://doi.org/10.1016/j.urolonc.2011.06.001" @default.
• W2109931581 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21803619" @default.
• W2109931581 hasPublicationYear "2013" @default.
• W2109931581 type Work @default.
• W2109931581 sameAs 2109931581 @default.
• W2109931581 citedByCount "3" @default.
• W2109931581 countsByYear W21099315812015 @default.
• W2109931581 countsByYear W21099315812016 @default.
• W2109931581 crossrefType "journal-article" @default.
• W2109931581 hasAuthorship W2109931581A5003431977 @default.
• W2109931581 hasAuthorship W2109931581A5012700479 @default.
• W2109931581 hasAuthorship W2109931581A5023328871 @default.
• W2109931581 hasAuthorship W2109931581A5037865295 @default.
• W2109931581 hasAuthorship W2109931581A5044713725 @default.
• W2109931581 hasAuthorship W2109931581A5047909222 @default.
• W2109931581 hasAuthorship W2109931581A5052686564 @default.
• W2109931581 hasAuthorship W2109931581A5056439371 @default.
• W2109931581 hasAuthorship W2109931581A5080856237 @default.
• W2109931581 hasAuthorship W2109931581A5086601750 @default.
• W2109931581 hasAuthorship W2109931581A5087735810 @default.
• W2109931581 hasConcept C126322002 @default.
• W2109931581 hasConcept C141071460 @default.
• W2109931581 hasConcept C143998085 @default.
• W2109931581 hasConcept C146357865 @default.
• W2109931581 hasConcept C151730666 @default.
• W2109931581 hasConcept C167135981 @default.
• W2109931581 hasConcept C2776694085 @default.
• W2109931581 hasConcept C2776938808 @default.
• W2109931581 hasConcept C2778074268 @default.
• W2109931581 hasConcept C2778119113 @default.
• W2109931581 hasConcept C2778239845 @default.
• W2109931581 hasConcept C71924100 @default.
• W2109931581 hasConcept C86803240 @default.
• W2109931581 hasConceptScore W2109931581C126322002 @default.
• W2109931581 hasConceptScore W2109931581C141071460 @default.
• W2109931581 hasConceptScore W2109931581C143998085 @default.
• W2109931581 hasConceptScore W2109931581C146357865 @default.
• W2109931581 hasConceptScore W2109931581C151730666 @default.
• W2109931581 hasConceptScore W2109931581C167135981 @default.
• W2109931581 hasConceptScore W2109931581C2776694085 @default.
• W2109931581 hasConceptScore W2109931581C2776938808 @default.
• W2109931581 hasConceptScore W2109931581C2778074268 @default.
• W2109931581 hasConceptScore W2109931581C2778119113 @default.
• W2109931581 hasConceptScore W2109931581C2778239845 @default.
• W2109931581 hasConceptScore W2109931581C71924100 @default.
• W2109931581 hasConceptScore W2109931581C86803240 @default.
• W2109931581 hasIssue "4" @default.
• W2109931581 hasLocation W21099315811 @default.
• W2109931581 hasLocation W21099315812 @default.
• W2109931581 hasOpenAccess W2109931581 @default.
• W2109931581 hasPrimaryLocation W21099315811 @default.
• W2109931581 hasRelatedWork W1989200792 @default.
• W2109931581 hasRelatedWork W2058542141 @default.
• W2109931581 hasRelatedWork W2068859133 @default.
• W2109931581 hasRelatedWork W2109931581 @default.
• W2109931581 hasRelatedWork W2119963083 @default.
• W2109931581 hasRelatedWork W2399304643 @default.
• W2109931581 hasRelatedWork W2412908548 @default.
• W2109931581 hasRelatedWork W2588090585 @default.
• W2109931581 hasRelatedWork W2600735778 @default.
• W2109931581 hasRelatedWork W2410020921 @default.

• next